U.S. Market for Drug-Eluting & Bare Metal Stents 2009

Published: May 2009
No. of Pages: 65

Price

In 2008, the U.S. market for drug eluting stents was valued at $1.95 billion, representing an increase of 1.6% over 2007. Overall average selling prices are predicted to decrease over the forecast period. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.

U.S. Market for Drug-Eluting & Bare Metal Stents 2009

TABLE OF CONTENTS

U.S. MARKET FOR DRUG-ELUTING AND BARE METAL STENTS 2009................I

TABLE OF CONTENTS..................................................................................................... II

LIST OF FIGURES...............................................................................................................V

LIST OF CHARTS..............................................................................................................VI

EXECUTIVE SUMMARY................................................................................................... 1

1.1 MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES ............................................. 1

1.2 BARE-METAL AND DRUG-ELUTING STENTS ................................................................ 1

1.3 PTCA AND CUTTING BALLOONS.................................................................................. 1

1.4 BALLOON-INFLATION SYRINGES AND ANGIOPLASTY KITS ......................................... 2

1.5 INTERVENTIONAL CATHETERS ..................................................................................... 2

1.6 INTERVENTIONAL GUIDEWIRES.................................................................................... 2

1.7 EMBOLIC PROTECTION DEVICES .................................................................................. 3

1.8 ATHERECTOMY DEVICES.............................................................................................. 3

1.9 THROMBECTOMY DEVICES........................................................................................... 4

1.10 CHRONIC TOTAL OCCLUSION CROSSERS ................................................................... 4

1.11 INTRODUCER SHEATHS............................................................................................... 5

1.12 VASCULAR CLOSURE DEVICES................................................................................... 5

1.13 DIAGNOSTIC CORONARY CATHETERS AND GUIDEWIRES .......................................... 6

1.14 FRACTIONAL FLOW RESERVE GUIDEWIRES ............................................................... 7

1.15 IVUS CATHETERS....................................................................................................... 8

1.16 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES .............................................. 9

1.17 VULNERABLE PLAQUE DEVICES............................................................................... 10

1.18 PFO, ASD AND VSD DEVICES ................................................................................. 10

1.19 PERCUTANEOUS MITRAL VALVE REPAIR DEVICES.................................................. 10

1.20 AORTIC HEART VALVE REPLACEMENT DEVICES..................................................... 10

1.21 LEADING COMPETITORS ........................................................................................... 11

Table of Contents

iii

RESEARCH METHODOLOGY....................................................................................... 13

2.1 RESEARCH SCOPE ....................................................................................................... 13

2.2 IDATA’S 9-STEP METHODOLOGY ............................................................................... 13

2.2.1 Step 1: Project Initiation & Team Selection ...................................................... 14

2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research..................... 15

2.2.3 Step 3: Preparation for Interviews & Questionnaire Design ............................ 16

2.2.4 Step 4: Performing Primary Research............................................................... 17

2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates ............................ 19

2.2.6 Step 6: Market Forecast and Analysis ............................................................... 19

2.2.7 Step 7: Identify Strategic Opportunities ............................................................ 21

2.2.8 Step 8: Final Review and Market Release ......................................................... 22

2.2.9 Step 9: Customer Feedback and Market Monitoring......................................... 23

BARE-METAL AND DRUG-ELUTING STENTS.......................................................... 24

3.1 INTRODUCTION ........................................................................................................... 24

3.2 POPULATION AT RISK ................................................................................................. 26

3.3 PROCEDURE NUMBERS ............................................................................................... 30

3.4 MARKET ANALYSIS & FORECAST .............................................................................. 32

3.4.1 Units Sold by Type ................................................................................................ 35

3.4.2 Bare-Metal Stent Market ...................................................................................... 37

3.4.2.1 Bare-Metal Stent Market Drivers ....................................................................39

3.4.2.2 Bare-Metal Stent Market Limiters ...................................................................39

3.4.3 Drug-Eluting Stent Market ................................................................................... 41

3.4.3.1 Drug-Eluting Stent Market Drivers .................................................................44

3.4.3.2 Drug-Eluting Stent Market Limiters ................................................................45

3.4.4 Stents in Development........................................................................................... 47

3.4.4.1 Bioabsorbable Stents .......................................................................................48

3.4.4.2 Bifurcated Stents..............................................................................................50

3.5 STENT MARKET BY DELIVERY PLATFORM................................................................. 52

3.6 STENT MARKET BY SIZE............................................................................................. 54

3.7 COMPETITIVE ANALYSIS ............................................................................................ 56

3.7.1 Bare-Metal Stents ................................................................................................. 56

3.7.2 Drug-Eluting Stents .............................................................................................. 58

3.7.3 Potential New Market Participants ...................................................................... 62

Table of Contents

ABBREVIATIONS.............................................................................................................. 65

List of Figures

LIST OF FIGURES

EXECUTIVE SUMMARY.................................................................................... 1

RESEARCH METHODOLOGY.......................................................................... 13

BARE-METAL AND DRUG-ELUTING STENTS............................................... 24

Figure 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005

– 2015 ........................................................................................................... 27

Figure 4-2: Angiography and Angioplasty Procedures, U.S., 2005 – 2015............ 30

Figure 4-3: Market for Coronary Stents by Type, U.S., 2005 – 2015.................... 33

Figure 4-4: Units Sold, Market for Coronary Stents, U.S., 2005 – 2015 ............... 35

Figure 4-5: Coronary Stent Units by Type, U.S., 2005 – 2015 ............................. 36

Figure 4-6: Market for Bare-Metal Stents, U.S., 2005 – 2015 .............................. 37

Figure 4-7: Market Drivers and Limiters, Market for Bare-Metal Stents, U.S.,

2008 .............................................................................................................. 40

Figure 4-8: Market for Drug-Eluting Stents, U.S., 2005 – 2015 ........................... 42

Figure 4-9: Market Drivers and Limiters, Market for Drug-Eluting Stents, U.S.,

2008 .............................................................................................................. 46

Figure 4-10: Coronary Stent Platforms in Development Not Approved by the

FDA, 2008..................................................................................................... 47

Figure 4-11: Potential Market for Bioabsorbable Stents, U.S., 2013 – 2015 ......... 49

Figure 4-12: Potential Market for Bifurcated Stents, U.S., 2010 – 2015 ............... 51

Figure 4-13: Market for Coronary Stents by Delivery Platform, Units Sold, U.S.,

2005 – 2015................................................................................................... 52

Figure 4-14: Market for Coronary Stents by Size, U.S., 2008 .............................. 54

Figure 4-15: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008 ...... 57

Figure 4-16: Leading Competitors, U.S. Market for Drug-Eluting Stents, 2008 .... 60

ABBREVIATIONS ............................................................................................ 65

List of Charts

LIST OF CHART S

EXECUTIVE SUMMARY.................................................................................... 1

Chart 1-1: Market for Interventional Cardiology Devices, U.S., 2008 .................... 1

Chart 1-2: Market for Coronary Stents, U.S., 2005 – 2015..................................... 1

Chart 1-3: Coronary Atherectomy Devices Market, U.S., 2005 – 2015................... 3

Chart 1-4: Coronary CTO Crosser Market, U.S., 2005 – 2015 ............................... 4

Chart 1-5: Coronary Vascular Closure Devices, U.S., 2005 – 2015 ........................ 5

Chart 1-6: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005

– 2015 ............................................................................................................. 6

Chart 1-7: Penetration Rate of FFR Guidewires in PCI Procedures, U.S., 2005 -

2015 ................................................................................................................ 7

Chart 1-8: Number of IVUS Catheter Units Sold, U.S., 2005 – 2015...................... 8

Chart 1-9: Optical Coherence Tomography Catheter Market, U.S., 2010 – 2015 .... 9

Chart 1-10: Leading Competitors, Market for Interventional Cardiology, U.S.,

2008 .............................................................................................................. 11

RESEARCH METHODOLOGY.......................................................................... 13

BARE-METAL AND DRUG-ELUTING STENTS............................................... 24

Chart 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005

– 2015 ........................................................................................................... 28

Chart 4-2: Age Group Most Likely to Undergo Cardiac Intervention: 60 to 69

Years Old, U.S., 2005 – 2015......................................................................... 29

Chart 4-3: Angioplasty and Angiography Procedures, U.S., 2005 – 2015 ............. 31

Chart 4-4: Market for Coronary Stents by Type, U.S., 2005 – 2015 ..................... 34

Chart 4-5: Coronary Stent Units by Type, U.S., 2005 – 2015............................... 36

Chart 4-6: Market for Bare-Metal Stents, U.S., 2005 – 2015................................ 38

Chart 4-7: Market for Drug-Eluting Stents, U.S., 2005 – 2015............................. 43

Chart 4-8: Penetration Rate for Bioabsorbable Stents, U.S., 2013 – 2015............. 49

Chart 4-9: Penetration Rate for Bifurcated Stents, U.S., 2010 – 2015 .................. 51

List of Charts

vii

Chart 4-10: Market for Coronary Stents by Delivery Platform, Units Sold, U.S.,

2005 – 2015................................................................................................... 53

Chart 4-11: Market for Coronary Stents by Size, U.S., 2008 ................................ 55

Chart 4-12: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008 ....... 57

Chart 4-13: Leading Competitors, Market for Drug-Eluting Stents, U.S., 2008 .... 61

ABBREVIATIONS ............................................................................................ 65

Published By: iData Research
Product Code: iData Research1127

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:

Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Report SummaryGlobalData’s new report, Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the ...
Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
GlobalData’s new report, provides key data, information and analysis on the globa...
Drug Eluting Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
GlobalData’s new report, provides key data, information ...
Global Drug Eluting Stents Market 2010-2014
TechNavio analysts forecast that the Global Drug Eluting Stents market will reach $5.7 Billion in 2014. One of the key factors contributing to this mar...
The Drug-Eluting Stent Market Outlook to 2016
IntroductionThe DES market has seen tremendous growth since the introduction of DES in 2003, but the market suffered setbacks in 2007 on the release of clinical data...
Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
GlobalData’s report, provides key data, information and analysis on the global drug elutin...
Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016
GlobalData’s report is an essential source of information and analys...
European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden,...
Europe Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth
GlobalData’s report is an essential source of data and analy...
US Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth
GlobalData’s report is an essential source of data and analysis on t...

Connect With Us

Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way.

More about our Subscription option

Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: